Skip to main
BIOX

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions demonstrates a positive outlook due to its strong performance outside of Argentina, particularly in the crop protection segment, which continues to gain traction in international markets. The company is well-positioned to benefit from a potential turnaround in Argentine farmer demand, while also capitalizing on robust international opportunities for its HB4 wheat in regions such as the US, Brazil, and Australia. Additionally, the momentum in bio-protection products and increased adjuvant sales in Brazil further supports Bioceres' capacity for revenue growth amidst challenges in the domestic market.

Bears say

Bioceres Crop Solutions is facing a significant decline in revenues across key segments, primarily due to weaker demand for Crop Protection and Crop Nutrition solutions in Argentina, which has been compounded by the company's transition to a licensing-based model that has reduced revenue from HB4-related sales. Crop Nutrition revenue decreased approximately 34% year-over-year to around $25 million, reflecting softer demand and pricing pressures, particularly in the micro-beaded fertilizer markets, attributed to reduced corn acreage throughout FY25. Additionally, revenues from Seed and Integrated products plummeted approximately 75% year-over-year to about $8 million as the company restructured its HB4 program, effectively exiting seed production and commercial sales.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.